Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Human Microbiome

University of British Columbia

$99,725.00

The Role of the Gastrointestinal Microbiota in Asthma

FY 2008-09

Summary
Allergic asthma is an ever-increasing problem in developed countries and affects approximately 20% of all Canadians. Although there are many theories about the potential cause of asthma, the actual causes remain undefined. Recent evidence suggests that shifts in resident microbiota (normal flora) may play a significant role in atopic diseases such as asthma (the so- called "hygiene hypothesis"). However, the role of the gastrointestinal microbiota in asthma has not been explored experimentally, and no attempt has been made to identify microbial populations that may be associated with, or more importantly, hinder development of asthma. In this application we propose to explore the contribution of the microbiota to asthma. We will use a well characterized murine model of asthma to determine if the microbiota plays a role in this disease. This will be achieved by varying the microbiota using different antibiotics, characterizing resulting population shifts using a variety of techniques, and then inducing asthma. The microbiota of antibiotic pretreated animals will also be reconstituted with microbiota from susceptible and resistant populations. Collectively, these approaches will provide key information about the role of the intestinal microbiota in asthma, and identify a specific subset associated with asthma. It will also provide novel insights into the effect of antibiotics on the intestinal flora, and bring together investigators with very different skills all working on a common problem. Ultimately this information could be used to develop new ways of treating asthma.
Program
Catalyst Grant: Human Microbiome
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
172983
Name
Finlay Barton B
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Human Microbiome
Projecttitle
The Role of the Gastrointestinal Microbiota in Asthma
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$99,725
Cihrequipment2
$0
Programname2
Catalyst Grant: Human Microbiome
Keyworddelim
Antibiotics; Asthma; Atopic Diseases; Intestinal Flora; Microbiota
Abstract
Allergic asthma is an ever-increasing problem in developed countries and affects approximately 20% of all Canadians. Although there are many theories about the potential cause of asthma, the actual causes remain undefined. Recent evidence suggests that shifts in resident microbiota (normal flora) may play a significant role in atopic diseases such as asthma (the so- called "hygiene hypothesis"). However, the role of the gastrointestinal microbiota in asthma has not been explored experimentally, and no attempt has been made to identify microbial populations that may be associated with, or more importantly, hinder development of asthma. In this application we propose to explore the contribution of the microbiota to asthma. We will use a well characterized murine model of asthma to determine if the microbiota plays a role in this disease. This will be achieved by varying the microbiota using different antibiotics, characterizing resulting population shifts using a variety of techniques, and then inducing asthma. The microbiota of antibiotic pretreated animals will also be reconstituted with microbiota from susceptible and resistant populations. Collectively, these approaches will provide key information about the role of the intestinal microbiota in asthma, and identify a specific subset associated with asthma. It will also provide novel insights into the effect of antibiotics on the intestinal flora, and bring together investigators with very different skills all working on a common problem. Ultimately this information could be used to develop new ways of treating asthma.
Competitiondate
200808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Finlay, Barton B
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $50,000~ $0~Inst of Infection & Immunity~ $49,725~ $0~